Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Genetics and Molecular Research

Hybrid Quantum–Machine Learning Models For High-Dimensional Gene Expression Profiling And Early Risk Prediction Of Parkinson’s And Alzheimer’s Disease

S. Beula Princy, Mary Jacob, Sarala G, S Rajanaryanan, S Kannan, R. Naveenkumar, Deepender

Published Jan 1, 2026• 0 citations
Publisher

Abstract

Molecular changes in the early stage of Parkinson’s disease (PD) and Alzheimer disease (AD) occur before disease onset, and thus, transcriptomic profiling could be an effective approach to risk prediction in the early phases of the disease. Nonetheless, the generated datasets of gene expression are very high-dimensional usually having thousands of genes with few samples, that are not readily accommodated by traditional machine learning methods, which face the risk of overfitting and low nonlinear representational properties. Strong computational models are thus needed to obtain discriminative molecular signatures and generalise at the same time. This work suggests a quantum-machine learning (QML) framework to profile high-dimensional gene expression to enhance prediction of the early risk of both PD and AD and maintain biological insights. Most public transcriptomic datasets were preprocessed with log transformation, Z-score normalisation, and then they were subjected to the analysis of differential expression and mutually informative feature selection. The encoding of the genes of interest into a variational quantum circuit was through angle encoding, which allowed nonlinear representation to a higher-dimensional feature space. Regularised cross-entropy loss was used to train a hybrid quantum -classical architecture that used parameterized quantum layers followed by a classical classifier. Accuracy, precision, recall, F1-score and ROC-AUC were used to measure performance that was benchmarked against support vector machines, random forests and classical neural networks. This model proposed was more successful in higher ROC-AUC, F1-scores in single datasets of PD, and AD, and showed greater ability to perform in high-dimensional and small samples. The process of neuroinflammation via genes associated with neuroinflammatory pathways, mitochondrial dysfunction, and synaptic signaling were determined by feature importance analyses and pathway enrichment as per known neurodegenerative mechanisms.

DOI
10.4238/trjq2j23

Related papers

Quantum-classical hybrid learning framework for Parkinson’s disease prediction using acoustic and clinical features

Jiahua Li, N. Rama Rao, C. H. N. Santhosh Kumar +4 more

Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting millions worldwide, where early and accurate diagnosis plays a critical role in improving patient outcomes. While classical machine learning methods have shown strong performance in PD classification using clinical and acoustic data, they remain limited in capturing complex nonlinear feature interactions in high-dimensional spaces. This study explores the application of quantum machine learning (QML) techniques for PD prediction, focusing on Variational Quantum Classifiers (VQC) and Quantum Support Vector Machines (QSVM), and compares their performance with strong classical baselines including Logistic Regression, SVM, Random Forest, Grid Search–optimized models, and XGBoost. Experiments were conducted using stratified train–test splits and validated through cross-validation and statistical testing. Results show that classical models achieve competitive performance, with XGBoost reaching 91.9% accuracy. However, quantum models demonstrate slightly improved performance, with the VQC using EfficientSU2 achieving the highest accuracy of 93.1%, followed by the Real Amplitudes VQC (92.6%) and QSVM (92.2%). These improvements are consistent across evaluation metrics including F1-score and recall. Statistical analysis using 10-fold cross-validation indicates that the VQC (EfficientSU2) shows a significant improvement over classical baselines ( p = 0.031), while other quantum models do not achieve statistical significance over XGBoost ( p > 0.05). McNemar’s test on the independent test set confirms no significant difference in final prediction distributions between quantum and classical models. Overall, the findings suggest that quantum machine learning models are competitive with state-of-the-art classical approaches, offering marginal but consistent performance gains. This study highlights the potential of quantum-enhanced learning frameworks for biomedical classification tasks, while also emphasizing that their advantages remain incremental rather than definitive under current simulation-based implementations.

Scientific Reports•Jul 23, 2026•0 citations

Quantum Support Vector Machines for Early Detection of Neurodegenerative Disorders Using Multimodal Brain Imaging

Akinyemi Omololu Akinrotimi, Joseph Bamidele Awotunde, Omotosho Israel Oluwabusayo

The prompt detection of neurodegenerative diseases (NDDs) like Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), and Parkinson's Disease (PD) is essential yet difficult. This research proposes a hybrid quantum-classical machine learning methodology to categorize NDD using multimodal brain imaging data.ADNI and PPMI datasets' MRI, PET, and fMRI images were preprocessing by Python-based tools such as Scikit-image, SimpleITK, and FreeSurfer via Nipype. Major steps were denoising, registration, normalization, segmentation, and extraction of features from structural and functional imaging. Training was done with a Quantum Support Vector Machine (QSVM) using Qiskit's ZZFeatureMap and QuantumKernel and compared with a conventional SVM. Performance measures-precision, recall, F1-score, class accuracy, AUC, and 10-fold cross-validation-were calculated. QSVM performed better than the standard SVM on all metrics, with 91.25% overall accuracy and macro F1-score of 0.913 as opposed to 87.75% and 0.879 for the SVM. The results validate QSVM's advantage in handling complex, high-dimensional neuroimaging data and its relevance to aiding clinical diagnosis. Keywords: Quantum Machine Learning, Neuroimaging, QSVM, Alzheimer’s Disease, Parkinson’s Disease, Multimodal Classification

Malaysian Journal of Science and Advanced Technology•Sep 17, 2025•0 citations

An efficient hybrid quantum machine learning framework for Alzheimer classification

Tajinder Kumar, Neha Chachra, Purushottam Sharma +3 more

Abstract Neuro-imaging data is necessary for timely and correct diagnosis of the disease Alzheimer’s (AD). Early clinical intervention is challenging due to the high-dimensional nature of the images, making it computationally difficult to work on representations, sparse annotated datasets and inter-subject variance. Deep convolutional VGG, ResNet, DenseNet, MobileNet and other neural networks (CNNs) have shown good performance. Diagnostic performance, but they are based on a high number of parameters and require highly trained personnel. Data can often times restrict resilience to data-skimy clinical settings. To address these challenges, the current paper presents a hybrid Quantum Machine Learning (QML) architecture for Alzheimer’s disease Detection and classification based on a combination of classical CNN-based feature extraction and Variational quantum classifier. In the suggested method, diseased, relevant, and compact features are extracted using pre-trained CNN backbones. Data from structural MRI scans is later translated into quantum states and computed. With parameterised variational quantum circuits optimised with a hybrid quantum-classical learning loop. The proposed method has been experimentally evaluated on benchmark datasets of MRI scans of Alzheimer’s patients. The hybrid CNNQML model has a mean classification accuracy of about 93% which is similar to deep CNN models, including ResNet and DenseNet (94%), and much more. Beating lightweight models like MobileNet and shallow CNNs by six percentage points. It is worth noting that the hybrid QML model performs better in conditions with limited training data. Performance degradation is observed in accuracy and AUC for all CNN variants, with up to 5% lower performance to deep CNNs. Cross-validation, confidence interval, paired significance test, and statistical validation. Effect size analysis proves the fact that the hybrid model produces statistically significant performance, as well as cases of clinically meaningful improvements over lightweight CNN baselines. Similar to the state-of-the-art deep networks with significantly reduced trainable parameters in the classification stage. These findings show that hybrid QML is a data-efficient and powerful substitute in the diagnosis of Alzheimer’s. On the whole, this is a work that sets a practical way to integrate quantum machine learning into clinical neuro-imaging pipelines and hybrid settings. QML has supplementary deep-learning enhancement to classics in next-generation Alzheimer’s Decision-support systems.

Scientific Reports•Aug 5, 2026•0 citations

Early Detection of Chronic Diseases Using Quantum Machine Learning Algorithms

N. Deepika, P. RaniAnnapurna, T. Satya Kavyanjali +2 more

Early diagnosis of chronic diseases is paramount to improving patient survival rates, optimizing treatment trajectories, and mitigating escalating healthcare expenditures. While the recent explosion of heterogeneous healthcare data presents robust opportunities for predictive modeling, it simultaneously introduces severe computational bottlenecks regarding data dimensionality and non-linear complexity. This paper proposes a novel, high-performance hybrid prediction framework that seamlessly fuses classical machine learning topologies with Variational Quantum Circuits (VQCs) within a Quantum Machine Learning (QML) paradigm. The proposed architecture targets the multi-classification and risk profiling of five high-prevalence chronic conditions: diabetes, cardiovascular disease, breast cancer, chronic liver disease, and chronic kidney disease This project introduces “Quantum Health,” a Quantum Machine Learning (QML)-based multi disease prediction system that integrates classical and quantum computing to enhance diagnostic performance. It employs five quantum-enhanced models: Quantum Random Forest for breast cancer, Quantum Neural Network for diabetes, Quantum k-Nearest Neighbors (QkNN) for heart disease, Quantum AdaBoost for liver disease, and Quantum Naive Bayes for kidney disease. The models are evaluated using both classical methods and PennyLane simulations, enabling direct comparison of performance. The system is deployed as a Flask-based web application featuring a user-friendly dashboard, disease-specific prediction modules, prediction history with CSV export, and an analytics dashboard comparing classical and quantum accuracies. Each module provides predictions, confidence scores, and feature importance insights. Unlike monolithic classical models, our approach incorporates a parameterized quantum layer that maps low-dimensional classical medical vectors into high-dimensional Hilbert spaces, capturing intricate, non-linear correlations that evade classical kernels. Experimental evaluations executed on simulated quantum backends demonstrate that the proposed Quantum Hybrid Model drastically outperforms conventional baselines, achieving an overall classification accuracy of 96.8% and an Area Under the Curve (AUC) of 98.4%. The findings establish that integrating quantum circuit state vectors with ensemble classical architectures provides a scalable, computationally efficient, and highly generalizable paradigm for next-generation clinical decision support systems.

SPU Journal of Science Technology and Management Research•Jul 1, 2026•0 citations

Hybrid Quantum-Assisted Deep Learning Model for Early-Stage Alzheimer’s Disease Classification Based on MRI Images

Eman A. Radhi, Mohammed Y. Kamil, Mazin Abed Mohammed

Alzheimer's disease (AD) presents significant diagnostic challenges owing to the subtle morphological similarities observed in the early stages, with traditional deep learning approaches often struggling to distinguish between the various stages of disease progression via structural Magnetic Resonance Imaging (MRI) data. Quantum computing offers unique advantages for medical image analysis, leveraging superposition and entanglement capabilities to process high-dimensional feature spaces beyond the limits of classical computation. This study introduces a hybrid quantum-classical neural network architecture (HQC-Net) for accurate four-class Alzheimer's disease classification, which uses quantum processing to detect patterns that are often invisible to classical spatial analysis methods. The proposed framework integrates classical feature extractors, including a custom CNN and modified ResNet18, with six-qubit variational quantum circuits that employ multiaxis rotation encoding (RY→RZ→RX), a quantum Fourier transform for spectral decomposition, and multihead attention for effective quantum-classical feature fusion. Comprehensive evaluations were conducted on the Kaggle dataset (5,121 samples) and the OASIS dataset (20,000 samples), incorporating realistic quantum noise modelling, including depolarising, amplitude damping, and phase damping channels. The modified QResNet18 configuration achieved a test accuracy of 99.67%, with perfect discriminative capability (AUC = 1.0000) on the OASIS dataset. Quantum processing demonstrated superior detection of very mild dementia (99.86% accuracy), which is crucial for early intervention. The proposed approach outperformed existing quantum-enhanced methods by 3.57 percentage points while effectively handling the increased diagnostic complexity associated with four-class classification. This study demonstrates a practical quantum advantage for multiclass neuroimaging classification, achieving superior diagnostic accuracy while maintaining computational efficiency and clinical deployment feasibility under current Noisy Intermediate-Scale Quantum (NISQ) hardware constraints.

Mesopotamian Journal of Big Data•Aug 30, 2025•2 citations

Detection of Parkinson’s Disease using Quantum Transformers

Arepalli Peda Gopi, Meghana Reddy Boddapati, Geetha Chiranji +3 more

Parkinson disease (PD) is a neurological progressive disease that mainly impacts on speech, motor coordination and mobility, which causes a major reduction in the quality of life of patients. Timely and proper diagnosis is paramount to effective treatment, managing the symptoms, and monitoring the disease. As more biomedical data including voice signals and EEG recordings have become accessible, machine learning (ML) and artificial intelligence (AI) methods have been popular in automated PD detection. Traditional methods have shown good results through the use of Convolutional Neural Networks (CNN), Long Short-Term Memory (LSTM), BiLSTM, Random Forest, and the Quantum Generative Adversarial Networks (QGAN). Nevertheless, these models are usually said to be limited by being computationally expensive, relying on large labeled datasets, the inability to deal with high-dimensional sequential data, limited ability to learn long-range temporal interactions, and the vanishing gradient problem. In order to cope with these issues, this paper presents a new Quantum Transformer-based system of Parkinson’s disease detection. The suggested model encodes voice features into quantum states and uses quantum self-attention mechanisms to effectively express the long-range dependencies and subtle interactions of feature. The hybrid quantum-classical learning architecture is applied to merge the benefits of quantum computation and the benefits of efficient classical optimization methods. According to experimental findings, the proposed Quantum Transformer is always more accurate, precise, and has a higher recall and $\mathrm{F1}$-score than the existing models. Also, the model has lower value of losses, consistent convergence, and it has minimized overfitting. These results demonstrate that quantum-enhanced transformer-based architectures can be a reliable scalable solution to the clinical decision-support systems of the future that can be used to detect Parkinson’s disease early and accurately.

International Conference on Next Generation Electronics (NELEX)•May 8, 2026•0 citations
Molecular changes in the early stage of Parkinson’s disease (PD) and Alzheimer disease (AD) occur before disease onset, and thus, transcriptomic profiling could be an effective approach to risk prediction in the early phases of the disease. Nonetheless, the generated datasets of gene expression are very high-dimensional usually having thousands of genes with few samples, that are not readily accommodated by traditional machine learning methods, which face the risk of overfitting and low nonlinear representational properties. Strong computational models are thus needed to obtain discriminative molecular signatures and generalise at the same time. This work suggests a quantum-machine learning (QML) framework to profile high-dimensional gene expression to enhance prediction of the early risk of both PD and AD and maintain biological insights. Most public transcriptomic datasets were preprocessed with log transformation, Z-score normalisation, and then they were subjected to the analysis of differential expression and mutually informative feature selection. The encoding of the genes of interest into a variational quantum circuit was through angle encoding, which allowed nonlinear representation to a higher-dimensional feature space. Regularised cross-entropy loss was used to train a hybrid quantum -classical architecture that used parameterized quantum layers followed by a classical classifier. Accuracy, precision, recall, F1-score and ROC-AUC were used to measure performance that was benchmarked against support vector machines, random forests and classical neural networks. This model proposed was more successful in higher ROC-AUC, F1-scores in single datasets of PD, and AD, and showed greater ability to perform in high-dimensional and small samples. The process of neuroinflammation via genes associated with neuroinflammatory pathways, mitochondrial dysfunction, and synaptic signaling were determined by feature importance analyses and pathway enrichment as per known neurodegenerative mechanisms.
Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting millions worldwide, where early and accurate diagnosis plays a critical role in improving patient outcomes. While classical machine learning methods have shown strong performance in PD classification using clinical and acoustic data, they remain limited in capturing complex nonlinear feature interactions in high-dimensional spaces. This study explores the application of quantum machine learning (QML) techniques for PD prediction, focusing on Variational Quantum Classifiers (VQC) and Quantum Support Vector Machines (QSVM), and compares their performance with strong classical baselines including Logistic Regression, SVM, Random Forest, Grid Search–optimized models, and XGBoost. Experiments were conducted using stratified train–test splits and validated through cross-validation and statistical testing. Results show that classical models achieve competitive performance, with XGBoost reaching 91.9% accuracy. However, quantum models demonstrate slightly improved performance, with the VQC using EfficientSU2 achieving the highest accuracy of 93.1%, followed by the Real Amplitudes VQC (92.6%) and QSVM (92.2%). These improvements are consistent across evaluation metrics including F1-score and recall. Statistical analysis using 10-fold cross-validation indicates that the VQC (EfficientSU2) shows a significant improvement over classical baselines ( p = 0.031), while other quantum models do not achieve statistical significance over XGBoost ( p > 0.05). McNemar’s test on the independent test set confirms no significant difference in final prediction distributions between quantum and classical models. Overall, the findings suggest that quantum machine learning models are competitive with state-of-the-art classical approaches, offering marginal but consistent performance gains. This study highlights the potential of quantum-enhanced learning frameworks for biomedical classification tasks, while also emphasizing that their advantages remain incremental rather than definitive under current simulation-based implementations.
The prompt detection of neurodegenerative diseases (NDDs) like Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), and Parkinson's Disease (PD) is essential yet difficult. This research proposes a hybrid quantum-classical machine learning methodology to categorize NDD using multimodal brain imaging data.ADNI and PPMI datasets' MRI, PET, and fMRI images were preprocessing by Python-based tools such as Scikit-image, SimpleITK, and FreeSurfer via Nipype. Major steps were denoising, registration, normalization, segmentation, and extraction of features from structural and functional imaging. Training was done with a Quantum Support Vector Machine (QSVM) using Qiskit's ZZFeatureMap and QuantumKernel and compared with a conventional SVM. Performance measures-precision, recall, F1-score, class accuracy, AUC, and 10-fold cross-validation-were calculated. QSVM performed better than the standard SVM on all metrics, with 91.25% overall accuracy and macro F1-score of 0.913 as opposed to 87.75% and 0.879 for the SVM. The results validate QSVM's advantage in handling complex, high-dimensional neuroimaging data and its relevance to aiding clinical diagnosis. Keywords: Quantum Machine Learning, Neuroimaging, QSVM, Alzheimer’s Disease, Parkinson’s Disease, Multimodal Classification
Abstract Neuro-imaging data is necessary for timely and correct diagnosis of the disease Alzheimer’s (AD). Early clinical intervention is challenging due to the high-dimensional nature of the images, making it computationally difficult to work on representations, sparse annotated datasets and inter-subject variance. Deep convolutional VGG, ResNet, DenseNet, MobileNet and other neural networks (CNNs) have shown good performance. Diagnostic performance, but they are based on a high number of parameters and require highly trained personnel. Data can often times restrict resilience to data-skimy clinical settings. To address these challenges, the current paper presents a hybrid Quantum Machine Learning (QML) architecture for Alzheimer’s disease Detection and classification based on a combination of classical CNN-based feature extraction and Variational quantum classifier. In the suggested method, diseased, relevant, and compact features are extracted using pre-trained CNN backbones. Data from structural MRI scans is later translated into quantum states and computed. With parameterised variational quantum circuits optimised with a hybrid quantum-classical learning loop. The proposed method has been experimentally evaluated on benchmark datasets of MRI scans of Alzheimer’s patients. The hybrid CNNQML model has a mean classification accuracy of about 93% which is similar to deep CNN models, including ResNet and DenseNet (94%), and much more. Beating lightweight models like MobileNet and shallow CNNs by six percentage points. It is worth noting that the hybrid QML model performs better in conditions with limited training data. Performance degradation is observed in accuracy and AUC for all CNN variants, with up to 5% lower performance to deep CNNs. Cross-validation, confidence interval, paired significance test, and statistical validation. Effect size analysis proves the fact that the hybrid model produces statistically significant performance, as well as cases of clinically meaningful improvements over lightweight CNN baselines. Similar to the state-of-the-art deep networks with significantly reduced trainable parameters in the classification stage. These findings show that hybrid QML is a data-efficient and powerful substitute in the diagnosis of Alzheimer’s. On the whole, this is a work that sets a practical way to integrate quantum machine learning into clinical neuro-imaging pipelines and hybrid settings. QML has supplementary deep-learning enhancement to classics in next-generation Alzheimer’s Decision-support systems.
Early diagnosis of chronic diseases is paramount to improving patient survival rates, optimizing treatment trajectories, and mitigating escalating healthcare expenditures. While the recent explosion of heterogeneous healthcare data presents robust opportunities for predictive modeling, it simultaneously introduces severe computational bottlenecks regarding data dimensionality and non-linear complexity. This paper proposes a novel, high-performance hybrid prediction framework that seamlessly fuses classical machine learning topologies with Variational Quantum Circuits (VQCs) within a Quantum Machine Learning (QML) paradigm. The proposed architecture targets the multi-classification and risk profiling of five high-prevalence chronic conditions: diabetes, cardiovascular disease, breast cancer, chronic liver disease, and chronic kidney disease This project introduces “Quantum Health,” a Quantum Machine Learning (QML)-based multi disease prediction system that integrates classical and quantum computing to enhance diagnostic performance. It employs five quantum-enhanced models: Quantum Random Forest for breast cancer, Quantum Neural Network for diabetes, Quantum k-Nearest Neighbors (QkNN) for heart disease, Quantum AdaBoost for liver disease, and Quantum Naive Bayes for kidney disease. The models are evaluated using both classical methods and PennyLane simulations, enabling direct comparison of performance. The system is deployed as a Flask-based web application featuring a user-friendly dashboard, disease-specific prediction modules, prediction history with CSV export, and an analytics dashboard comparing classical and quantum accuracies. Each module provides predictions, confidence scores, and feature importance insights. Unlike monolithic classical models, our approach incorporates a parameterized quantum layer that maps low-dimensional classical medical vectors into high-dimensional Hilbert spaces, capturing intricate, non-linear correlations that evade classical kernels. Experimental evaluations executed on simulated quantum backends demonstrate that the proposed Quantum Hybrid Model drastically outperforms conventional baselines, achieving an overall classification accuracy of 96.8% and an Area Under the Curve (AUC) of 98.4%. The findings establish that integrating quantum circuit state vectors with ensemble classical architectures provides a scalable, computationally efficient, and highly generalizable paradigm for next-generation clinical decision support systems.
Alzheimer's disease (AD) presents significant diagnostic challenges owing to the subtle morphological similarities observed in the early stages, with traditional deep learning approaches often struggling to distinguish between the various stages of disease progression via structural Magnetic Resonance Imaging (MRI) data. Quantum computing offers unique advantages for medical image analysis, leveraging superposition and entanglement capabilities to process high-dimensional feature spaces beyond the limits of classical computation. This study introduces a hybrid quantum-classical neural network architecture (HQC-Net) for accurate four-class Alzheimer's disease classification, which uses quantum processing to detect patterns that are often invisible to classical spatial analysis methods. The proposed framework integrates classical feature extractors, including a custom CNN and modified ResNet18, with six-qubit variational quantum circuits that employ multiaxis rotation encoding (RY→RZ→RX), a quantum Fourier transform for spectral decomposition, and multihead attention for effective quantum-classical feature fusion. Comprehensive evaluations were conducted on the Kaggle dataset (5,121 samples) and the OASIS dataset (20,000 samples), incorporating realistic quantum noise modelling, including depolarising, amplitude damping, and phase damping channels. The modified QResNet18 configuration achieved a test accuracy of 99.67%, with perfect discriminative capability (AUC = 1.0000) on the OASIS dataset. Quantum processing demonstrated superior detection of very mild dementia (99.86% accuracy), which is crucial for early intervention. The proposed approach outperformed existing quantum-enhanced methods by 3.57 percentage points while effectively handling the increased diagnostic complexity associated with four-class classification. This study demonstrates a practical quantum advantage for multiclass neuroimaging classification, achieving superior diagnostic accuracy while maintaining computational efficiency and clinical deployment feasibility under current Noisy Intermediate-Scale Quantum (NISQ) hardware constraints.
Parkinson disease (PD) is a neurological progressive disease that mainly impacts on speech, motor coordination and mobility, which causes a major reduction in the quality of life of patients. Timely and proper diagnosis is paramount to effective treatment, managing the symptoms, and monitoring the disease. As more biomedical data including voice signals and EEG recordings have become accessible, machine learning (ML) and artificial intelligence (AI) methods have been popular in automated PD detection. Traditional methods have shown good results through the use of Convolutional Neural Networks (CNN), Long Short-Term Memory (LSTM), BiLSTM, Random Forest, and the Quantum Generative Adversarial Networks (QGAN). Nevertheless, these models are usually said to be limited by being computationally expensive, relying on large labeled datasets, the inability to deal with high-dimensional sequential data, limited ability to learn long-range temporal interactions, and the vanishing gradient problem. In order to cope with these issues, this paper presents a new Quantum Transformer-based system of Parkinson’s disease detection. The suggested model encodes voice features into quantum states and uses quantum self-attention mechanisms to effectively express the long-range dependencies and subtle interactions of feature. The hybrid quantum-classical learning architecture is applied to merge the benefits of quantum computation and the benefits of efficient classical optimization methods. According to experimental findings, the proposed Quantum Transformer is always more accurate, precise, and has a higher recall and F1\mathrm{F1}F1-score than the existing models. Also, the model has lower value of losses, consistent convergence, and it has minimized overfitting. These results demonstrate that quantum-enhanced transformer-based architectures can be a reliable scalable solution to the clinical decision-support systems of the future that can be used to detect Parkinson’s disease early and accurately.